This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1352458508100038v1 15/4/437    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kneider, M Articles by Andersen, O Search for Related Content PubMed PubMed Citation Articles by Kneider, M Articles by Andersen, O Social Bookmarking                         What's this?

Sequence analysis of human rhinovirus aspirated from the nasopharynx of patients with relapsing-remitting MS

¹ Institute of Clinical Neuroscience and Physiology, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden
² Department of Infectious Diseases, Section of Clinical Virology, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden
³ Department of Mathematic Statistics, Chalmers University of Technology, Gothenburg, Sweden

^* To whom correspondence should be addressed.

	Abstract

Background

Upper respiratory infections were reported to trigger multiple sclerosis relapses. A relationship between picornavirus infections and MS relapses was recently reported.

Objective

To evaluate whether human rhinovirus is associated with multiple sclerosis relapses and whether any particular strain is predominant.

Method

Nasopharyngeal fluid was aspirated from 36 multiple sclerosis patients at pre-defined critical time points. Reverse-transcriptase-PCR was performed to detect human rhinovirus-RNA. Positive amplicons were sequenced.

Results

We found that rhinovirus RNA was present in 17/40 (43%) of specimens obtained at the onset of a URTI in 19 patients, in 1/21 specimens during convalescence after URTI in 14 patients, in 0/6 specimens obtained in 5 patients on average a week after the onset of an "at risk" relapse, occurring within a window in time from one week before to three weeks after an infection, and in 0/17 specimens obtained after the onset of a "not at risk" relapse not associated with any infection in 12 patients. Fifteen specimens from healthy control persons not associated with URTI were negative. The frequency of HRV presence in URTI was similar to that reported for community infections. Eight amplicons from patients represented 5 different HRV strains.

Conclusion

We were unable to reproduce previous findings of association between HRV infections and multiple sclerosis relapses. HRV was not present in nasopharyngeal aspirates obtained during "at risk" or "not at risk" relapses. Sequencing of HRV obtained from patients during URTI did not reveal any strain with predominance in multiple sclerosis.

Key Words: ???

First published on February 27, 2009, doi:10.1177/1352458508100038

Multiple Sclerosis 2009;15:437.

A more recent version of this article appeared on April 1, 2009


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?